Exablate 4000; Exablate Transcarnial MRgFUS; Exablate Neuro; Exablate Prime; ExAblate Neuravive
FDA premarket approval P150038/S040 · decided 2025-04-04
Approval details
- PMA number
- P150038
- Supplement
- S040
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Exablate 4000; Exablate Transcarnial MRgFUS; Exablate Neuro; Exablate Prime; ExAblate Neuravive
- Generic name
- MR-guided focused ultrasound system
- Applicant
- Insightec
- Date received
- 2025-03-07
- Decision date
- 2025-04-04
- Days to decision
- 28 days
- Decision code
- OK30
- Product code
- POH
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Tirat Carmel
- Statement
- a change to the in-process testing for ferromagnetic content
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.